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Introduction
Botulinum neurotoxin (BoNT) is among the most toxic proteins, 
which is produced by the gram-positive bacterium Clostridium 
botulinum, and it is the etiological agent of botulism (Schiavo   
et al., 2000). BoNTs are classified into seven types (A–G) based 
on their serological specificity. Types A, B, E, and F cause botu-
lism in both humans and animals. In contrast, types C and D 
cause botulism mainly in animals, and clinically significant dis-
ease associated with types C and D is rarely seen in humans 
(Arnon et al., 2001). BoNTs target peripheral nerve endings 
where they proteolytically cleave SNARE proteins inhibiting 
neurotransmitter release (Schiavo et al., 2000). In food-borne 
botulism, the orally ingested toxin must pass through the intestinal 
epithelial barrier to enter the systemic circulation from the gut 
lumen. Multiple studies have examined the mechanism of toxin 
transit across the intestinal epithelial barrier (Maksymowych 
and Simpson, 1998; Couesnon et al., 2008), but this remains 
controversial (Simpson, 2004; Poulain et al., 2008).
There are two forms of the type B BoNTs consisting of large 
protein complexes (BoNT/B complexes) referred to as the 12S and 
16S toxins, in which nontoxic components are attached to BoNT   
(Sakaguchi, 1982; Oguma et al., 1999). BoNT with nontoxic 
non-HA (NTNH) constitutes the 12S toxin, and the 16S toxin is 
comprised of BoNT, NTNH, and HA, which itself is made up of three 
proteins, HA1, -2, and -3 (Fig. 1 A). These nontoxic components 
protect BoNT from the low pH and enzymes encountered in the di-
gestive tract after oral ingestion, and these nontoxic factors greatly 
contribute to the oral toxicity of the BoNT complex (Ohishi et al., 
1977; Sugii et al., 1977). We recently identified another role for the 
HA component of type B 16S toxin: this protein complex disrupts 
the intestinal epithelial intercellular junction and facilitates the 
transepithelial delivery of BoNT. We proposed that this activity 
contributes to the pathogenesis of food-borne botulism (Matsumura 
et al., 2008). In this study, we show that type B HA directly binds 
epithelial cadherin (E-cadherin) and thereby disrupts E-cadherin–
mediated cell to cell adhesion and, in turn, the epithelial barrier.
B
otulinum  neurotoxin  is  produced  by  Clostridium 
botulinum  and  forms  large  protein  complexes 
through associations with nontoxic components. We 
recently found that hemagglutinin (HA), one of the non-
toxic components, disrupts the intercellular epithelial bar-
rier; however, the mechanism underlying this phenomenon 
is not known. In this study, we identified epithelial cadherin 
(E-cadherin) as a target molecule for HA. HA directly binds 
E-cadherin and disrupts E-cadherin–mediated cell to cell 
adhesion. Although HA binds human, bovine, and mouse 
E-cadherin,  it  does  not  bind  rat  or  chicken  E-cadherin   
homologues. HA does not interact with other members of 
the classical cadherin family such as neural and vascular 
endothelial cadherin. Expression of rat E-cadherin but not 
mouse rescues Madin–Darby canine kidney cells from 
HA-induced  tight  junction  (TJ)  disruptions.  These  data 
demonstrate that botulinum HA directly binds E-cadherin 
and disrupts E-cadherin–mediated cell to cell adhesion in 
a species-specific manner and that the HA–E-cadherin 
interaction is essential for the disruption of TJ function.
Botulinum hemagglutinin disrupts the intercellular 
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HA was immobilized via its Strep tag. Using this approach, we 
reproducibly purified five proteins with molecular masses of 
100 kD from the human intestinal epithelial cell line Caco-2 
(Fig. 1 B). Mass spectrometric analysis identified these proteins as 
E-cadherin, a transmembrane protein that mediates Ca
2+-dependent 
intercellular adhesion (Yoshida-Noro et al., 1984; Hatta et al., 
1985), and its cytoplasmic binding proteins, -catenin, -catenin, 
Results and discussion
We generated recombinant type B HA comprised of Strep-tagged 
HA1, Flag-tagged HA2, and Flag-tagged HA3, and these pro-
teins formed functional complexes comparable to native 16S toxin 
when assembled in vitro (unpublished data). We then purified HA-
binding proteins using an affinity column in which recombinant 
Figure 1.  Botulinum HA binds to E-cadherin. (A) Schematic representation of the BoNT complexes. (B) Purification of HA binding proteins. Caco-2 cell 
lysates were loaded on a Strep-Tactin column prebound with HA. As a control, cell lysates were passed over a bare Strep-Tactin column, or a buffer was 
passed over a column containing HA. HA and associated proteins were eluted, and the eluates were further purified using anti-Flag M2 gel. HA and 
HA-binding proteins were eluted with low pH buffer (pH 3.5), separated by SDS-PAGE, and detected by silver stain (left). Alternatively, HA-binding proteins 
were eluted with EDTA and NaCl (right). Detected bands were excised and processed for mass spectrometric analysis, and the identified proteins are indi-
cated (arrows). (C) Caco-2 cells were treated with trypsin in the presence of Ca
2+ (TC) or EDTA (TE) before the extraction, and cell lysates were subjected 
to a HA pull-down assay followed by immunoblotting with antibodies for the indicated proteins. The HA proteins were detected by Coomassie blue stain. 
(D) The E-cadherin extracellular domain protein was pulled down with Strep-Tactin gel loaded with HA, but Ca
2+ chelation by 5 mM EGTA prevented 
this interaction. (E) E-cadherin was pulled down from Caco-2 cell lysates with Strep-Tactin gel loaded with Strep-tagged HA1, Strep-tagged HA3, or the 
indicated combination of HA subunits (top). Flag-tagged HA2 was coupled to anti-Flag M2 gel and used for pull-down assay (bottom). HA1 and -2 do not 
form stable complexes.693 Botulinum HA disrupts E-cadherin function • Sugawara et al.
residue mutations in the mouse protein to identify residues that 
abrogate binding. Among these, replacement of Asn20 with Arg 
(Mouse-N20R) markedly reduced the interaction with HA in a 
pull-down assay (Fig. 3 D and Fig. S3). This residue is not 
directly involved in E-cadherin trans-dimerization, but it is 
located near the cadherin dimer interface (Boggon et al., 2002). 
Cells expressing Mouse-N20R remained susceptible to the 
effects of HA, but to a lesser extent than cells expressing wild-
type mouse E-cadherin, and the reciprocal mutation (Rat-R20N) 
conferred only partial HA binding (Fig. 3, D and E). These re-
sults indicate that Asn20 is directly involved in the interaction 
of mouse E-cadherin with HA or located in close proximity to 
the interaction surface of them, but it seems likely that addi-
tional residues in EC1 contribute to this interaction.
We next examined whether the EC1 domain is sufficient 
for mediating the interaction of E-cadherin with HA using bac-
terially expressed EC domain proteins. In a HA pull-down assay, 
neither EC1 nor the extended construct EC144, which harbors 
EC1 and some residues of EC2, interacted with HA, but a con-
struct containing the full EC1 and EC2 domains (EC1/2) was suc-
cessfully pulled down with HA (Fig. 3, F and G). The interaction 
of EC1/2 with HA was comparable with that of the full-length EC 
domain protein expressed in mammalian cells (EC-full), and this 
interaction was Ca
2+ dependent (Fig. 3 G). Thus, EC1 is neces-
sary but not sufficient for the interaction of HA with E-cadherin, 
and both EC1 and -2 are required for full HA binding. Addition-
ally, because the EC1/2 construct was produced in bacteria, it is 
clear that no posttranslational modifications of E-cadherin are 
needed to mediate its interaction with HA.
Epithelial cells form junctional complexes in which tight 
junctions (TJs), E-cadherin–based adherens junctions, and des-
mosomes are aligned from the apical surface at sites of cell to 
cell contact (Farquhar and Palade, 1963). Claudins are localized 
to the TJ and provide an important barrier function by prevent-
ing the paracellular influx of water, ions, and solutes (Furuse et al., 
1998; Sonoda et al., 1999). Thus, HA would not have access to 
E-cadherin from the apical face of the cells, and this is consis-
tent with our previous observation that the basolateral membrane 
is the site of HA action (Matsumura et al., 2008). When HA was 
added to the apical surface of Caco-2 cell monolayers, it was 
bound and internalized into early endosomes that costained with 
EEA1 (early endosome antigen 1; Fig. 4 B). 1 h after HA appli-
cation, it reached the basal surface, presumably through trans-
cytosis, and partially localized to the lateral cellular membrane 
with E-cadherin (Fig. 4 C). In contrast, in MDCK I cells, which 
were insensitive to apically applied HA but were sensitive when 
treated basolaterally, binding and internalization of HA was sub-
stantially reduced compared with Caco-2 cells, probably because 
of the lack of presumptive apical receptors for HA. Furthermore, 
large amounts of basolateral HA staining were not seen (Fig. 4, 
A–C). Although the detailed mechanism remains to be eluci-
dated, HA transcytosis is required to achieve the proper colocal-
ization of HA with E-cadherin in polarized epithelial cells. 
Under physiological conditions, intestinal M cells sample luminal 
antigens through high rates of transcytosis (Neutra et al., 2001), 
and these cells are thought to be the site of HA transcytosis in 
addition to enterocytes.
and  plakoglobin/-catenin  (Ozawa  et  al.,  1989).  We  con-
firmed these results using a HA pull-down assay followed by   
immunoblotting. Additionally, when E-cadherin was depleted   
by treating the cells with trypsin in the absence of Ca
2+, the 
catenins no longer coprecipitated with HA, suggesting that HA 
directly interacts with the extracellular region of E-cadherin 
(Fig. 1 C). This interaction was also detected by preincubating 
cells with HA (Fig. S1, A and B). Furthermore, using a recom-
binant extracellular domain of E-cadherin, we confirmed the di-
rect interaction of HA with E-cadherin and the dependence of 
this interaction on the presence of Ca
2+ (Fig. 1 D). Although 
weak binding was observed between E-cadherin and a complex 
consisting of HA2 and -3, all three HA subunits were needed for 
full binding (Fig. 1 E).
We next examined the interaction of the native 16S toxin 
with E-cadherin. Both types B and A 16S toxins interacted with 
E-cadherin, but type C 16S toxin did not (Fig. S1 C). Interest-
ingly, we previously showed that types A and B but not C 16S 
toxin disrupt the intercellular junction of Caco-2 cells (Jin et al., 
2009). Collectively, these data suggest that the HA–E-cadherin 
interaction may be related to the disruption of intercellular junc-
tions (see Fig. 5).
E-cadherin is a canonical member of the cadherin family, 
which has at least 80 members (Yagi and Takeichi, 2000). We 
examined the specificity of the HA interaction with cadherins 
by comparing HA binding to three classical cadherins, E-cadherin, 
neural cadherin (N-cadherin), and vascular endothelial cadherin 
(VE-cadherin), using L cells stably expressing EGFP-tagged cad-
herins. In a HA pull-down assay, the interaction was specific to 
E-cadherin (Fig. 2 A). When recombinant HA was applied to 
the E-cadherin–expressing cells, localization of E-cadherin around 
the cell boundaries was lost, E-cadherin clusters appeared on 
the cell surface, and E-cadherin was also internalized (Fig. 2,   
B and C). In contrast, HA had no effect on cadherin localization 
or internalization in cells expressing N- or VE-cadherin (Fig. 2 B). 
E-cadherin cleavage was not observed after HA treatment 
(Fig. 2 D). Thus, HA specifically disrupted E-cadherin–mediated 
cell to cell adhesion without proteolytic E-cadherin cleavage.
We then examined the ability of HA to interact with   
E-cadherin derived from different species using L cells stably 
expressing human, bovine, mouse, rat, or chicken E-cadherin 
(LCAM). HA bound to human, bovine, and mouse E-cadherin, but 
no binding was seen for rat and chicken E-cadherin (Fig. 3 A). 
Consistent with this, HA disrupted cell adhesion mediated by 
human-, bovine-, and mouse-derived E-cadherin (Fig. 3 B).
To identify the critical region of E-cadherin responsible 
for binding to HA, we generated chimeric constructs in which 
the extracellular cadherin (EC) domains of rat E-cadherin were 
sequentially replaced by the corresponding domains from mouse 
E-cadherin (Fig. 3 C). Replacement of the distal EC domain of 
rat E-cadherin with the corresponding domain from mouse 
E-cadherin (Rat-m1) was sufficient to mediate HA interaction 
and L cell dissociation (Fig. 3, D and E). Thus, the EC1 domain, 
which is known to mediate interactions between cells in trans 
(for review see Shapiro and Weis, 2009), appears to be critically 
involved in its interaction with HA. The mouse and rat EC1 do-
mains differ by only 9 aa residues, and we generated single JCB • VOLUME 189 • NUMBER 4 • 2010   694
Figure 2.  Botulinum HA disrupts E-cadherin but not N-cadherin– and VE-cadherin–mediated cell adhesion. (A) Cell lysates prepared from L cells stably 
expressing EGFP, E-cadherin–EGFP (E-L), N-cadherin–EGFP (N-L), and VE-cadherin–EGFP (VE-L) were subjected to a HA pull-down assay followed by   
immunoblotting with specific antibodies for each protein. The asterisk denotes nonspecific bands. (B) Confocal images of EGFP fluorescence of the L cells 
pretreated with or without 100 nM HA for 6 h. E-cadherin–EGFP formed clusters (arrowheads). (C) E-L cells treated as in B were stained with the mono-
clonal antibody DECMA-1, which recognizes the extracellular region of E-cadherin (Ozawa et al., 1990), before permeabilization. After permeabilization, 
E-cadherin–EGFP was labeled with an anti–E-cadherin antibody that recognizes the intracellular domain of E-cadherin. E-cadherin–EGFP costained with 
these two antibodies is localized to the cell surface (arrowheads), and E-cadherin–EGFP stained only with the anti–intracellular domain antibody indicates 
internalized protein (arrows). (D) E-L cells treated as in B were lysed in SDS-PAGE sample buffer and analyzed by immunoblotting using anti–E-cadherin 
antibody. -Tubulin was used as a loading control. IB, immunoblot. Bars, 20 µm.
E-cadherin mediates the formation and maintenance of the 
entire epithelial junctional complex, including TJs (Behrens et al., 
1985; Gumbiner and Simons, 1986; Gumbiner et al., 1988; 
Watabe et al., 1994; for review see Citi, 1993), although a recent 
study suggested that E-cadherin is not required for the mainte-
nance of TJs (Capaldo and Macara, 2007). We performed the 695 Botulinum HA disrupts E-cadherin function • Sugawara et al.
Figure 3.  E-cadherin EC1 and -2 domains are required for HA binding. (A) Human, mouse, and bovine but not rat and chicken E-cadherin bound HA. Cell 
lysates prepared from L cells stably expressing E-cadherin derived from each species were subjected to a HA pull-down assay followed by immunoblotting. 
(B) L cells were treated with or without 10 nM HA for 6 h, stained with an antibody against -catenin (red) to demonstrate cadherin-dependent cell to cell 
boundary localization. Nuclei were stained with Hoechst (blue). (C) Schematic representation of E-cadherin chimeras between mouse (closed) and rat 
(open). (D) Cell lysates from the L cells expressing E-cadherin chimeras were subjected to a HA pull-down assay followed by immunoblotting. (E) The extent 
of the disruption of E-cadherin–mediated cell–cell adhesion was quantified as the mean number of -catenin stain–positive cell–cell contacts per cell. A total 
of at least 250 cells were counted per condition in three independent experiments. Values are means ± SEM (*, P < 0.001). (F) Schematic representation 
of recombinant mouse EC domain proteins. (G) The recombinant EC domain proteins were subjected to a HA pull-down assay in the absence or presence 
of 5 mM EGTA followed by immunoblotting for E-cadherin. The asterisk and double asterisk denote HA3 and -1, respectively, which nonspecifically reacted 
with the antibody used. IB, immunoblot. Bar, 30 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   696
by HA was partially inhibited by the expression of Mouse-N20R 
(Fig. S2 C). Endogenous canine E-cadherin in rat E-cadherin–
expressing cells was pulled down by HA to a similar extent as 
in EGFP-expressing cells (Fig. 5 A). Moreover, in these cells, 
endogenous canine E-cadherin was cointernalized with HA, 
which is consistent with results seen in mouse E-cadherin–
expressing cells (Fig. 5 C). Nonetheless, exogenous rat E-cadherin 
and ZO-1, a TJ protein, were localized normally at intercellular 
junctions (Fig. 5, C and D). These observations indicate that 
exogenous rat E-cadherin is capable of maintaining TJs despite 
HA-mediated disruption of endogenous canine E-cadherin func-
tion, and these data clearly demonstrate that E-cadherin plays a 
critical role in the disruption of TJs initiated by HA.
following experiments to confirm that HA disrupts TJs in an 
E-cadherin–dependent manner. We used MDCK I cell mono-
layers expressing EGFP alone or EGFP fused to mouse or rat 
E-cadherin. As described in the previous paragraph, MDCK I 
cells are susceptible to the effects of HA when treated basolater-
ally, and endogenous canine E-cadherin was pulled down by HA 
(Fig. 5 A). We applied HA to the basolateral surface of the cell 
monolayer and measured transepithelial electrical resistance 
(TER). Treatment with HA markedly reduced the TER of MDCK 
I cells expressing either EGFP or mouse E-cadherin–EGFP. 
However, rat E-cadherin–EGFP acted as a dominant negative, 
and cells expressing rat E-cadherin–EGFP maintained their TER 
even in the presence of HA (Fig. 5 B). The reduced TER induced 
Figure 4.  HA is transcytosed in Caco-2 cells. (A) Caco-2 and MDCK I cells were grown in Transwell chambers, and TER was measured in the presence 
() or absence (x) of HA applied to the apical (1 µM) or basolateral (100 nM) chamber. Values are means ± SEM (n = 3). (B) Caco-2 and MDCK I cell 
monolayers were apically treated with 100 nM HA for 30 min at 4°C. Cells were washed and incubated for an additional 30 min at 37°C. HA was labeled 
with E-cadherin or EEA1 using specific antibodies against each molecule. (C) Caco-2 and MDCK I cell monolayers were treated with 1 µM HA from the 
apical side for the indicated times. The basolateral surface was labeled with anti-HA antibody before permeabilization. After permeabilization, cells were 
labeled with anti–E-cadherin antibody. Right panels show a higher magnification image of the boxed region. Partial colocalization of HA (magenta) and 
E-cadherin (green) was observed (arrowheads). Bars: (B) 10 µm; (C) 30 µm.697 Botulinum HA disrupts E-cadherin function • Sugawara et al.
monitoring the influx of FITC-dextran in the serum. Like rat 
E-cadherin, guinea pig E-cadherin contains an Arg at its 20th 
aa (Lecuit et al., 1999), and it was unable to interact with HA 
(Fig. S3 A). In contrast to the results seen in mice, the nontoxic 
toxin component did not increase the absorption of FITC-dextran 
in rats or guinea pigs (Fig. S3). Thus, there is a strong in vivo 
Previously, we showed that the nontoxic component of the 
16S toxin (i.e., the complex of HA and NTNH) disrupts the in-
testinal epithelial barrier, leading to the absorption of the 12S 
toxin or soluble dextran in a mouse in situ loop assay (Matsumura 
et al., 2008). We performed this assay using rats and guinea 
pigs, and the disruption of the epithelial barrier was assessed by 
Figure 5.  The E-cadherin–HA interaction is critically involved in HA-mediated TJ disruption. (A) Cell lysates were prepared from MDCK I cells stably ex-
pressing EGFP, mouse E-cadherin–EGFP (Mouse-Ecad), or rat E-cadherin–EGFP (Rat-Ecad) and subjected to a HA pull-down assay followed by immunoblot-
ting. Arrowheads and arrows denote E-cadherin–EGFP and endogenous canine E-cadherin, respectively. (B) MDCK transfectants were grown in Transwell 
chambers, and TER was measured in the presence () or absence (x) of 100 nM HA applied to the basolateral chamber. Values are means ± SEM (n = 3). 
(C) Confocal images of exogenous E-cadherin (EGFP), mouse and endogenous canine E-cadherin (DECMA-1), and HA of the cells treated with or without 
100 nM HA for 24 h. Right panels show a higher magnification image of the boxed region. Endogenous E-cadherin (green) was cointernalized with HA 
(magenta; arrowheads). DECMA-1 recognizes mouse and canine but not rat E-cadherin. (D) Confocal images of ZO-1 of the cells treated with or without 
100 nM HA for 24 h. Bars: (C) 10 µm; (D) 30 µm.JCB • VOLUME 189 • NUMBER 4 • 2010   698
Cell culture and establishment of stably transfected cells
Caco-2 and MDCK I cells were cultured as previously described (Jin et al., 
2009). IEC-18 (rat intestinal epithelial cells) and GPC-16 cells (guinea pig 
colon adenocarcinoma cells) were obtained from the American Type Culture 
Collection and cultured according to the supplier’s protocol. CMT93-I cells 
(mouse rectal carcinoma cells; Inai et al., 2008) were provided by T. Inai 
(Kyushu University, Higashi-ku, Fukuoka, Japan).
L and MDCK I cells were transfected with vectors encoding cad-
herins using Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s instructions. Stable transfectants were selected by limiting dilution 
in the presence of 1 mg/ml (L cells) or 0.25 mg/ml (MDCK I cells) hygro-
mycin B (Invitrogen). Expression of exogenous cadherins was confirmed 
by immunoblotting.
Immunofluorescence
Cells grown on Transwell pore filters or glass coverslips were fixed with 4% 
paraformaldehyde in PBS for 20 min and permeabilized with 0.5% Triton 
X-100 in PBS for 5 min at room temperature. Monolayers or coverslips 
were incubated with primary antibodies, probed with secondary antibodies 
coupled to Alexa Fluor 405, Alexa Fluor 488 (Invitrogen), or Cy3 (Jackson 
ImmunoResearch Laboratories, Inc.), and mounted with ProLong Antifade 
kit (Invitrogen). Images were captured with a microscope (IX71; Olympus) 
equipped with UPlan-Apochromat 100× NA 1.35 oil or Plan-Apochromat 
60× NA 1.40 oil objectives (Olympus) and a CSU-21 or CSU-X1 confocal 
scanner unit (Yokogawa). Images were analyzed with MetaMorph imag-
ing software (version 6.3r5; Universal Imaging).
Protein expression and purification
Recombinant  HAs  were  expressed  as  N-terminal  Strep-tagged  or  Flag-
tagged proteins in the Escherichia coli strains Rosetta (DE3) (EMD) or 
BL21-CodonPlus (DE3)-RIL (Agilent Technologies), and purified using the 
Strep-Tactin MacroPrep resin (EMD) and anti-Flag M2 resin (Sigma-Aldrich), 
respectively, according to the manufacturers’ protocols. For the reconstitu-
tion of the HA complex, the recombinant HA1, -2, and -3 proteins were 
mixed at a molar ratio of 2:2:1 in PBS, pH 7.4, and incubated for 3 h at 
37°C. The molarity of the HA complex was expressed as that of HA3. The 
extracellular domains (1–543 aa) of mouse E-cadherin were expressed in 
HEK293 cells as a C-terminally hexa-His–tagged protein and purified with 
a HisTrap column (GE Healthcare).
The  recombinant  mouse  EC  domain  proteins  (EC1,  1–104  aa; 
EC144, 1–144 aa; and EC1/2, 1–219 aa) were expressed in E. coli strain 
BL21-CodonPlus (DE3)-RIL as GST fusion proteins with a Factor Xa cleav-
age site adjacent to first Asp (Häussinger et al., 2004) and with a hexa-His 
tag at the C terminus. The proteins were purified with a GSTrap column 
(GE Healthcare), cleaved with Factor Xa (EMD), and further purified with 
the HisTrap column.
Purification of HA-binding proteins
Caco-2 cells were homogenized by being passed through a 24-gauge needle 
10 times. The soluble fraction was removed by centrifugation (15,500 g for 
10 min), and the resultant pellet was lysed in lysis buffer (10 mM Tris-HCl,   
pH 7.4, 1 mM MgCl2, 1 mM CaCl2, 150 mM NaCl, and 1% Triton X-100) 
supplemented with an EDTA-free protease inhibitor (Roche). Unsolubilized 
material was removed by ultracentrifugation (120,000 g for 1 h). The cell   
lysate was loaded on the Strep-Tactin MacroPrep column prebound with HA 
(a complex of Strep-HA1, Flag-HA2, and Flag-HA3), followed by extensive 
washing with lysis buffer. The HA and the HA-bound proteins were eluted 
from the resin with lysis buffer supplemented with 2.5 mM desthiobiotin and 
further purified using anti-Flag M2 resin.
HA pull-down assay
Cells stably expressing cadherins were solubilized in lysis buffer, and the cell 
lysates were incubated with the Strep-Tactin Superflow agarose (EMD) pre-
bound with HA (a complex of Strep-HA1, Flag-HA2, and Strep-HA3). When 
the recombinant E-cadherin extracellular domain constructs were subjected to 
a HA pull-down assay, the protein concentration was adjusted to 50 nM in a 
Hepes buffer (20 mM Hepes-NaOH, pH 7.35, 2 mM CaCl2, 150 mM NaCl, 
and 0.01% Triton X-100).
In situ loop assay
In situ loop assay was performed as described previously (Kondoh et al., 
2005; Matsumura et al., 2008) except that animals were anesthetized with 
pentobarbital Na. In brief, mice, rats, and guinea pigs were not fed for 24 h 
before surgery. A ligated intestinal loop (mice, 3.5–4.5 cm; and rats and 
guinea pigs, 4.5–5.5 cm of length) was made in the upper small intestine, 
and 10 mg/ml FITC-dextran 4k (Sigma-Aldrich) with or without 5 µM of the 
correlate to our observations in vitro, and the interaction of HA 
with E-cadherin seems to play a pivotal role in inducing epithe-
lial barrier disruption in vivo.
Several pathogens target E-cadherin to facilitate host 
invasion. Listeria monocytogenes and Candida albicans bind 
E-cadherin, leading to internalization (Mengaud et al., 1996; Phan 
et al., 2007). Alternatively, Bacteroides fragilis, Porphyromonas   
gingivalis, and C. albicans produce proteases that cleave   
E-cadherin, leading to epithelial barrier disruption and tissue in-
vasion (Obiso et al., 1997; Wu et al., 1998; Katz et al., 2000, 2002; 
Frank and Hostetter, 2007; Villar et al., 2007). Although the mode 
of action of botulinum HA is more similar to that used by the 
latter pathogens, it does not proteolytically cleave E-cadherin. 
Disruption of the epithelial barrier by HA might facilitate the 
influx and dissemination of BoNT into the systemic circulation.
In this study, we showed that the HA–E-cadherin inter-
action is restricted to particular species, and, for example, HA of 
the BoNT/B complex did not interact with chicken E-cadherin. 
Interestingly, this observation is consistent with the rare reports 
of avian botulism caused by BoNT/B. Furthermore, birds were 
experimentally shown to be relatively resistant to BoNT/B com-
plex, especially when administered orally (Gross and Smith, 
1971; Notermans et al., 1980). Additionally, the inability of 
BoNT/C complex to associate with human E-cadherin is cor-
related with the fact that human type C botulism is rarely seen   
despite the ability of BoNT/C to block neuromuscular transmis-
sion in human tissue (Coffield et al., 1997). Collectively, these 
data suggest that the interaction of HA with E-cadherin is an 
important factor determining host susceptibility for orally in-
gested BoNT complexes. This hypothesis could be tested using 
a similar approach as that used in studies of L. monocytogenes 
infection (Lecuit et al., 2001; Disson et al., 2008), namely by 
comparing the oral toxicity of BoNT/B complex in wild-type 




Antibodies for E-cadherin were purchased from BD, Sigma-Aldrich, Takara 
Bio Inc., and Invitrogen. An anti–VE-cadherin antibody was purchased from 
Santa Cruz Biotechnology, Inc. Anti–N-cadherin, anti–-catenin, anti–-catenin, 
antiplakoglobin  (-catenin),  and  anti-EEA1  antibodies  were  purchased 
from BD. Anti–Pan-cadherin and anti–-tubulin antibodies were purchased 
from Sigma-Aldrich. Rabbit anti–type A 16S, BoNT/A, type B 16S, and 
BoNT/B antisera were generated by immunizing rabbits with the respec-
tive forms of the toxins prepared as described previously (Matsumura et al., 
2008; Jin et al., 2009). Rabbit anti–type C 16S and BoNT/C antisera 
were provided by S. Kozaki (Osaka Prefecture University, Nakaku, Sakai, 
Osaka, Japan).
Plasmid construction
Mouse E-, N-, and VE-cadherin cDNAs were described previously (Nagafuchi 
et al., 1987; Miyatani et al., 1989; Kametani and Takeichi, 2007). Human, 
bovine, rat, and chicken E-cadherin cDNA clones were amplified from the 
total RNA of Caco-2 (American Type Culture Collection), MDBK, NBT-T1 
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